According to Bloomberg, Chicago-based venture capital firm 81 Collection has raised $82 million for its second fund. The firm previously invested in Colossal Biosciences; this funding amount represents 81 Collection's fundraise rather than a financing round of the same size completed by Colossal Biosciences.